Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Danaher Corporation stock logo
DHR
Danaher
$224.15
-1.5%
$224.42
$160.93
▼
$242.80
$157.67B0.764.39 million shs844,906 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Danaher Corporation stock logo
DHR
Danaher
-0.37%-1.95%+1.24%+3.71%+2.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Danaher Corporation stock logo
DHR
Danaher
$224.15
-1.5%
$224.42
$160.93
▼
$242.80
$157.67B0.764.39 million shs844,906 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Danaher Corporation stock logo
DHR
Danaher
-0.37%-1.95%+1.24%+3.71%+2.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Danaher Corporation stock logo
DHR
Danaher
2.78
Moderate Buy$242.918.37% Upside

Current Analyst Ratings Breakdown

Latest DHR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/27/2026
Danaher Corporation stock logo
DHR
Danaher
DowngradeStrong-Buy ➝ Hold
10/22/2026
Danaher Corporation stock logo
DHR
Danaher
Reiterated RatingBuy$260.00
10/22/2026
Danaher Corporation stock logo
DHR
Danaher
Reiterated RatingBuy$275.00
10/22/2026
Danaher Corporation stock logo
DHR
Danaher
Boost Price TargetBuy$230.00 ➝ $270.00
10/22/2026
Danaher Corporation stock logo
DHR
Danaher
Boost Price TargetOverweight$255.00 ➝ $260.00
10/22/2026
Danaher Corporation stock logo
DHR
Danaher
Boost Price TargetBuy$255.00 ➝ $270.00
10/22/2026
Danaher Corporation stock logo
DHR
Danaher
Boost Price TargetOverweight$250.00 ➝ $270.00
10/22/2026
Danaher Corporation stock logo
DHR
Danaher
Boost Price TargetBuy$220.00 ➝ $260.00
10/22/2026
Danaher Corporation stock logo
DHR
Danaher
Boost Price TargetOutperform$246.00 ➝ $254.00
10/13/2026
Danaher Corporation stock logo
DHR
Danaher
Boost Price TargetBuy$236.00 ➝ $255.00
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Danaher Corporation stock logo
DHR
Danaher
$24.57B6.42$11.15 per share20.10$76.23 per share2.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Danaher Corporation stock logo
DHR
Danaher
$3.61B$6.1136.6824.102.8716.91%11.17%6.71%1/27/2027 (Estimated)

Latest DHR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/21/2026Q3 2026
Danaher Corporation stock logo
DHR
Danaher
$1.92$2.11+$0.19$1.75$6.56 billion$6.55 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Danaher Corporation stock logo
DHR
Danaher
$1.600.71%+12.20%26.19%2 Years

Latest DHR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/15/2026
Danaher Corporation stock logo
DHR
Danaher
quarterly$0.400.72%9/30/20269/30/202610/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Danaher Corporation stock logo
DHR
Danaher
0.45
1.63
1.29

Institutional Ownership

CompanyInstitutional Ownership
Danaher Corporation stock logo
DHR
Danaher
79.05%

Insider Ownership

CompanyInsider Ownership
Danaher Corporation stock logo
DHR
Danaher
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Danaher Corporation stock logo
DHR
Danaher
60,000703.53 million627.55 millionOptionable

Recent News About These Companies

Promising Medical Stocks To Follow Now - November 19th
Danaher (NYSE:DHR) EVP Sells 2,100 Shares of Stock

New MarketBeat Followers Over Time

Media Sentiment Over Time

Danaher stock logo

Danaher NYSE:DHR

$224.15 -3.41 (-1.50%)
As of 11:16 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.